ClinicalTrials.gov
ClinicalTrials.gov Menu

Pegylated Liposomal Doxorubicin and Carboplatin as First Line Treatment for Patients With Advanced Non-small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01051362
Recruitment Status : Unknown
Verified January 2006 by The First Affiliated Hospital of Guangzhou Medical University.
Recruitment status was:  Recruiting
First Posted : January 18, 2010
Last Update Posted : January 18, 2010
Sponsor:
Information provided by:
The First Affiliated Hospital of Guangzhou Medical University